Molecular basis for defining the pineal gland and pinealocytes as targets for tumor necrosis factor.
The pineal gland, the gland that translates darkness into an endocrine signal by releasing melatonin at night, is now considered a key player in the mounting of an innate immune response. Tumor necrosis factor (TNF), the first pro-inflammatory cytokine to be released by an inflammatory response, suppresses the translation of the key enzyme of melatonin synthesis (arylalkylamine-N-acetyltransferase, Aanat). Here, we show that TNF receptors of the subtype 1 (TNF-R1) are expressed by astrocytes, microglia, and pinealocytes. We also show that the TNF signaling reduces the level of inhibitory nuclear factor kappa B protein subtype A (NFKBIA), leading to the nuclear translocation of two NFKB dimers, p50/p50, and p50/RelA. The lack of a transactivating domain in the p50/p50 dimer suggests that this dimer is responsible for the repression of Aanat transcription. Meanwhile, p50/RelA promotes the expression of inducible nitric oxide synthase (iNOS) and the production of nitric oxide, which inhibits adrenergically induced melatonin production. Together, these data provide a mechanistic basis for considering pinealocytes a target of TNF and reinforce the idea that the suppression of pineal melatonin is one of the mechanisms involved in mounting an innate immune response.
Laboratory of Chronopharmacology, Department of Physiology, Institute of Biosciences, Universidade de São Paulo São Paulo, Brazil.
Claudia Emanuele
CE
Carvalho-Sousa
Sanseray
S
da Silveira Cruz-Machado
Eduardo Koji
EK
Tamura
Pedro A C M
PA
Fernandes
Luciana
L
Pinato
Sandra M
SM
Muxel
Erika
E
Cecon
Regina P
RP
Markus